O Mounjaro e o Zepbound (ainda não disponível no Brasil), medicamentos da Eli Lilly, assim como os concorrentes Ozempic e Wegovy, da Novo Nordisk, geraram mais de US$ 40 bilhões no ano passado e devem atingir US$ 60 bilhões em vendas em 2025.
Leia mais (07/30/2025 – 13h06)
Related Posts
T.I. Barred From Using ‘Situationships’ Movie Title Amid Trademark Lawsuit
T.I. has been hit with a legal injunction that prohibits him from releasing his upcoming comedy movie under the title…
Virgin Music Group Shifts Physical Distribution Business to AMPED
Virgin Music Group, the indie distribution arm of Universal Music Group (UMG), is offloading a big chunk of its U.S.…
The best Prime Day deals under $50: Fire TV sticks, indoor cameras, and more
Best Prime Day deals under 2025 Best streaming deal Amazon Fire TV Stick 4K $24.99 (Save $25) Get Deal Best…